CN102423426A - Traditional Chinese drug composition for treating anaphylactoid purpura - Google Patents

Traditional Chinese drug composition for treating anaphylactoid purpura Download PDF

Info

Publication number
CN102423426A
CN102423426A CN2011104029683A CN201110402968A CN102423426A CN 102423426 A CN102423426 A CN 102423426A CN 2011104029683 A CN2011104029683 A CN 2011104029683A CN 201110402968 A CN201110402968 A CN 201110402968A CN 102423426 A CN102423426 A CN 102423426A
Authority
CN
China
Prior art keywords
parts
traditional chinese
radix
chinese drug
anaphylactoid purpura
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011104029683A
Other languages
Chinese (zh)
Other versions
CN102423426B (en
Inventor
孙胜波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rongcheng Research Institute Of Scientific & Technical Information
Original Assignee
Rongcheng Research Institute Of Scientific & Technical Information
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rongcheng Research Institute Of Scientific & Technical Information filed Critical Rongcheng Research Institute Of Scientific & Technical Information
Priority to CN201110402968.3A priority Critical patent/CN102423426B/en
Publication of CN102423426A publication Critical patent/CN102423426A/en
Application granted granted Critical
Publication of CN102423426B publication Critical patent/CN102423426B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a traditional Chinese drug composition for treating anaphylactoid purpura. The traditional Chinese drug composition comprises the following traditional Chinese drug raw materials, wherein the traditional Chinese drug raw materials comprise, by weight, 5-20 parts of mongolian milkvetch root, 5-15 parts of cassiabarktree twig, 5-20 parts of white peony root, 2-10 parts of prepared liauorice root, 5-20 parts of redroot gromwell, 5-20 parts of imperatae rhizome, 5-20 parts of hairyvein agrimonia herb, 2-10 parts of black cicada slough, 5-15 parts of common ducksmeat herb, 2-10 parts of common jujube, and 5-15 parts of pagodatree flower bud. The traditional Chinese drug composition of the present invention has effects of heat clearing and detoxicating, blood cooling and blood stasis dissipating, liver fire clearing and pathogenic fire reducing, yang enhancing and qi activating, qi benefiting, and artery and vein recovering, and provides a significant therapeutic effect for the anaphylactoid purpura. The treatment effect is reliable. The traditional Chinese drug composition has characteristics of wide sources of the drug components, simple preparation, mild medicine property, and no toxic and side-effect.

Description

A kind of Chinese medicine composition of treating anaphylactoid purpura
Technical field
The present invention relates to a kind of medicinal preparation of not confirming structure of traditional herbal medicines, especially a kind of Chinese medicine composition of treating anaphylactoid purpura.
Background technology
Anaphylactoid purpura is claimed purpura again, is blood capillary and arteriolar a kind of allergic angiitis of invading skin or other devices, and pilosity is born in male children, and characteristics are athrombopenic purpuras, normal companion's stomachache and joint symptom.Show as the skin petechia, come across around the joint of the lower extremity and buttocks more, purpura is symmetricals distribution, occurs in batches, differs in size, shade differs, and can merge in flakes, generally in a few days, disappears gradually, but can show effect repeatedly; The Western medicine of treating anaphylactoid purpura clinically mainly contains Claritin, like hismanal, chlorphenamine, calcium gluconate; Reduce the vascular permeability medicine, like carbazochrome salicylate, rutin, vitamin C; Anticoagulant medicine: like persantin; Adrenocortical hormone is like hydrocortisone, prednisone, dexamethasone.Adopt the western medicine anaphylactoid purpura can better temporarily solve symptom.But because body constitution, patients with anaphylactoid purpura is subject to the influence of environmental change, as weather turn cold, tired, angry, catch a cold, drink, eat and cause food hypersensitive etc., run into these situation regular meetings and cause the state of an illness to increase the weight of, and can take place repeatedly.Therefore, the western medicine anaphylactoid purpura exists the deficiency of curing the symptoms, not the disease.
The traditional Chinese medical science thinks that anaphylactoid purpura has the branch of deficiency and excess, and the case of a physically strong patient running a high fever is the high Sheng of gas fire, bleeding due to blood-heat; Deficient syndrome has for the moon hinders deficiency-fire stirring up, burn blood network at two: one; One can not take the photograph blood for the deficiency of vital energy.In a word, disorderly contrary because of the gas fire, blood can not follow through causing the network blood trouble and overflow.The cause of disease is with being invaded by exogenous pathogen, intemperance of taking food, and the congestion retardance, the prolonged illness Qi and blood deficiency is main.
According to theory of Chinese medical science, to the pathogeny of anaphylactoid purpura, excess syndrome is main with clearing away heat and cooling blood, and deficiency syndrome are main with nourishing qi to stop, nourishing YIN to lower pathogenic fire, carry out dialectical composition of prescription, to reach the purpose of treating both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the just temporary transient symptom that solves of existing technological western medicines in treatment anaphylactoid purpura; Exist the deficiency of curing the symptoms, not the disease, the present invention provides a kind of and prepares conveniently, the medicine source is wide, cost is low, evident in efficacy, reliable effect, a kind of Chinese medicine composition of treating anaphylactoid purpura of having no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition of treating anaphylactoid purpura is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: Radix Astragali 5-20 part, Ramulus Cinnamomi 5-15 part, Radix Paeoniae Alba 5-20 part, Radix Glycyrrhizae Preparata 2-10 part, Radix Arnebiae (Radix Lithospermi) 5-20 part, Rhizoma Imperatae 5-20 part, Herba Agrimoniae 5-20 part, Periostracum Cicadae 2-10 part, Herba Spirodelae 5-15 part, Fructus Jujubae 2-10 part, Flos Sophorae Immaturus 5-15 part.
Optimal technical scheme of the present invention is: a kind of Chinese medicine composition of treating anaphylactoid purpura is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: 15 parts of the Radixs Astragali, 10 parts of Ramulus Cinnamomi, 12 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Rhizoma Imperataes, 15 parts of Herba Agrimoniaes, 6 parts of Periostracum Cicadaes, 10 parts in Herba Spirodelae, 3 parts in Fructus Jujubae, 8 parts of the Flos Sophorae Immaturus.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: the Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating take off admittedly, the effect of wind dispelling fortune poison; Ramulus Cinnamomi has the effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; The Radix Paeoniae Alba has the effect of clear and coherent blood vessels, nourishing blood to suppress the hyperactive liver, slow middle arresting sweating; Radix Glycyrrhizae Preparata has the effect of spleen reinforcing stomach function regulating, Yiqi and vein recovery; Radix Arnebiae (Radix Lithospermi) has the effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, detoxifcation rash; Rhizoma Imperatae has the effect of cooling blood for hemostasis, heat-clearing and toxic substances removing; Herba Agrimoniae has astringing to arrest bleeding, preventing the attack (or recurrence) of malaria antidotal effect; Periostracum Cicadae has the effect that diffusing wind heat extraction, lung qi dispersing are decided convulsion; Herba Spirodelae has that diaphoresis, Hang Shui are dispeled the wind, the effect of heat-clearing and toxic substances removing; Fructus Jujubae has the effect of invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind; The Flos Sophorae Immaturus has the effect of cooling blood for hemostasis, purging liver-fire.Drug component in the present composition is through dialectical compatibility; Complement each other using; Have synergism, play the effect of heat-clearing and toxic substances removing, cooling blood and removing stasis, purging liver-fire, supporing yang activating QI, Yiqi and vein recovery altogether, thereby the treatment of anaphylactoid purpura is reached the purpose of treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its simple and convenient preparation, the medicine source is wide, cost is low.It follows the prescription principle of medication of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 90%, and cure rate reaches 55%.
The specific embodiment
Below in conjunction with embodiment the present invention is further specified.
Embodiment 1
A kind of Chinese medicine composition of treating anaphylactoid purpura, it is made up of following Chinese medicine raw materials by weight proportion: Radix Astragali 15g, Ramulus Cinnamomi 10g, Radix Paeoniae Alba 12g, Radix Glycyrrhizae Preparata 6g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Imperatae 15g, Herba Agrimoniae 15g, Periostracum Cicadae 6g, Herba Spirodelae 10g, Fructus Jujubae 3g, Flos Sophorae Immaturus 8g.
Embodiment 2
A kind of Chinese medicine composition of treating anaphylactoid purpura, it is made up of following Chinese medicine raw materials by weight proportion: Radix Astragali 20g, Ramulus Cinnamomi 8g, Radix Paeoniae Alba 15g, Radix Glycyrrhizae Preparata 8g, Radix Arnebiae (Radix Lithospermi) 10g, Rhizoma Imperatae 5g, Herba Agrimoniae 10g, Periostracum Cicadae 4g, Herba Spirodelae 5g, Fructus Jujubae 10g, Flos Sophorae Immaturus 10g.
Embodiment 3
A kind of Chinese medicine composition of treating anaphylactoid purpura, it is made up of following Chinese medicine raw materials by weight proportion: Radix Astragali 10g, Ramulus Cinnamomi 5g, Radix Paeoniae Alba 5g, Radix Glycyrrhizae Preparata 10g, Radix Arnebiae (Radix Lithospermi) 12g, Rhizoma Imperatae 20g, Herba Agrimoniae 5g, Periostracum Cicadae 8g, Herba Spirodelae 12g, Fructus Jujubae 2g, Flos Sophorae Immaturus 12g.
Embodiment 4
A kind of Chinese medicine composition of treating anaphylactoid purpura, it is made up of following Chinese medicine raw materials by weight proportion: Radix Astragali 5g, Ramulus Cinnamomi 12g, Radix Paeoniae Alba 20g, Radix Glycyrrhizae Preparata 2g, Radix Arnebiae (Radix Lithospermi) 5g, Rhizoma Imperatae 10g, Herba Agrimoniae 20g, Periostracum Cicadae 10g, Herba Spirodelae 8g, Fructus Jujubae 5g, Flos Sophorae Immaturus 15g.
Embodiment 5
A kind of Chinese medicine composition of treating anaphylactoid purpura, it is made up of following Chinese medicine raw materials by weight proportion: Radix Astragali 8g, Ramulus Cinnamomi 15g, Radix Paeoniae Alba 10g, Radix Glycyrrhizae Preparata 5g, Radix Arnebiae (Radix Lithospermi) 20g, Rhizoma Imperatae 12g, Herba Agrimoniae 12g, Periostracum Cicadae 2g, Herba Spirodelae 15g, Fructus Jujubae 8g, Flos Sophorae Immaturus 5g.
Chinese medicine composition in the embodiment of the invention is produced medicament by the decocting method of routine.Concrete grammar is following: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15~20 minutes, add water again and do not have about 8 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, the back of boiling was with slow fire boiling 20~30 minutes; Second decocts, and decocts 15~20 minutes after water boils.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition of treating anaphylactoid purpura, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 60 examples, wherein male 39 examples, women 21 examples, 5~50 years old age.
Two, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Potion on the one, the about 250ml of twice extracting juice of decocting divides early, takes for late twice.Period in a medicine is avoided pungent, greasy article.
Three, criterion of therapeutical effect:
(1) recovery from illness: sings and symptoms disappears or basic the disappearance;
(2) produce effects: sings and symptoms is most of to take a turn for the better;
(3) effective: a sings and symptoms part takes a turn for the better;
(4) invalid; Sings and symptoms does not all have obvious improvement, symptom such as preceding.
Four, therapeutic effect: in this clinical observation case, took medicine 5-30 days 33 examples of fully recovering, produce effects 10 examples, effective 11 examples, invalid 6 examples.Toxic and side effects does not take place during the treatment.
Five, model case:
Case 1: Liu, man, 7 years old.Occur low grade fever, weary existing symptom behind the affection of exogenous wind-cold, follow-uply the skin purpura occurs, see more, differ in size, be aubergine, be higher than skin with two lower limb, and companion's abdominal part paroxysmal pain, arthralgia.Take the decoction 7 days of Chinese medicine composition of the present invention preparation, stomachache disappears, the joint pain relief, and skin purpura color is thin out, and part disappears; Continuous clothes 14 days, joint pain disappears, and only lower limb have a little skin purpura; The further consultation in 7 days of continuous clothes, all diseases disappear, and the skin purpura disappears, recovery from illness.
Case 2: poplar, woman, 9 years old.Edible seafood is irritated, the skin purpura occurs, is symmetricals distribution in the whole body and extremity, differs in size, shade differs, and merges in flakes then, and aubergine is higher than skin.Take the decoction 14 days of Chinese medicine composition of the present invention preparation, exceed the obvious deepening of erythema of skin in flakes; Continuous clothes 21 days, the whole body and extremity skin are bright and clean, and sleep improves, and the food of receiving is normal, recovery from illness.

Claims (2)

1. Chinese medicine composition of treating anaphylactoid purpura, it is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: Radix Astragali 5-20 part, Ramulus Cinnamomi 5-15 part, Radix Paeoniae Alba 5-20 part, Radix Glycyrrhizae Preparata 2-10 part, Radix Arnebiae (Radix Lithospermi) 5-20 part, Rhizoma Imperatae 5-20 part, Herba Agrimoniae 5-20 part, Periostracum Cicadae 2-10 part, Herba Spirodelae 5-15 part, Fructus Jujubae 2-10 part, Flos Sophorae Immaturus 5-15 part.
2. a kind of Chinese medicine composition of treating anaphylactoid purpura according to claim 1, it is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: 15 parts of the Radixs Astragali, 10 parts of Ramulus Cinnamomi, 12 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Rhizoma Imperataes, 15 parts of Herba Agrimoniaes, 6 parts of Periostracum Cicadaes, 10 parts in Herba Spirodelae, 3 parts in Fructus Jujubae, 8 parts of the Flos Sophorae Immaturus.
CN201110402968.3A 2011-12-07 2011-12-07 Traditional Chinese medicine composition for treating anaphylactoid purpura Expired - Fee Related CN102423426B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110402968.3A CN102423426B (en) 2011-12-07 2011-12-07 Traditional Chinese medicine composition for treating anaphylactoid purpura

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110402968.3A CN102423426B (en) 2011-12-07 2011-12-07 Traditional Chinese medicine composition for treating anaphylactoid purpura

Publications (2)

Publication Number Publication Date
CN102423426A true CN102423426A (en) 2012-04-25
CN102423426B CN102423426B (en) 2014-02-12

Family

ID=45957511

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110402968.3A Expired - Fee Related CN102423426B (en) 2011-12-07 2011-12-07 Traditional Chinese medicine composition for treating anaphylactoid purpura

Country Status (1)

Country Link
CN (1) CN102423426B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104352896A (en) * 2014-12-05 2015-02-18 济南高达信息技术有限公司 Traditional Chinese medicine preparation for treating angioneurotic edema
CN104587071A (en) * 2015-02-27 2015-05-06 韩建东 Traditional Chinese medicament for treating infantile blood-heat allergic purpura
CN104971231A (en) * 2015-07-09 2015-10-14 宋永欣 Traditional Chinese medicine composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicine composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
安虎: "中西医结合对过敏性紫癜性肾炎的防治对策", 《中国中医药现代远程教育》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104352896A (en) * 2014-12-05 2015-02-18 济南高达信息技术有限公司 Traditional Chinese medicine preparation for treating angioneurotic edema
CN104587071A (en) * 2015-02-27 2015-05-06 韩建东 Traditional Chinese medicament for treating infantile blood-heat allergic purpura
CN104971231A (en) * 2015-07-09 2015-10-14 宋永欣 Traditional Chinese medicine composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicine composition

Also Published As

Publication number Publication date
CN102423426B (en) 2014-02-12

Similar Documents

Publication Publication Date Title
CN102423402B (en) Traditional Chinese drug composition for treating night sweat
CN104758825A (en) Traditional Chinese medicine composition for treating amenorrhea
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN103007169A (en) Traditional Chinese medicine composition for treating insomnia
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN102423426B (en) Traditional Chinese medicine composition for treating anaphylactoid purpura
CN102416145A (en) Chinese medicinal composition for treating menstrual disorder
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN102406765B (en) Traditional Chinese medicine composition for treating acne
CN104587186A (en) Traditional Chinese medicinal composition for treating qi and blood deficiency
CN104606514A (en) Traditional Chinese medicine composition for treating kidney deficiency type tinnitus
CN102349957A (en) Traditional Chinese medicine composition for treating prurigo
CN106491971A (en) A kind of for treating Chinese medicine composition of pulpitiss and preparation method thereof
CN103550533B (en) Chinese medicine composition for treating headache during menstruation
CN105477619A (en) Traditional Chinese medicine composition for treating delayed menorrhea
CN102988776A (en) Traditional Chinese medicine composition for treating vertigo
CN105148235A (en) Traditional Chinese medicine combination treating postpartum hemorrhage
CN103330814A (en) Traditional Chinese medicine composition for treating deficiency of kidney yang
CN103816493B (en) A kind of Chinese medicine composition treating instability of kidney QI
CN103169898B (en) Traditional Chinese medicine composition for treating irregular menstruation
CN103285108B (en) Chinese medicinal composition treating lumbago
CN1277577C (en) Chinese traditional medicine for treating cerebral thrombosis, preparation method and application
CN105797124A (en) Traditional Chinese medicine composition for treating functional uterine bleeding
CN105833152A (en) Traditional Chinese medicine composition for treating endocrine dyscrasia
CN105663612A (en) Traditional Chinese medicine composition for treating ankylosing spondylitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140212

Termination date: 20141207

EXPY Termination of patent right or utility model